The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice.
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).
Join us and be a part of the largest oncology meeting in Pakistan. well as outcome research with publications in Science, PNAS, Gastroenterology, Lancet, and NEJM. The impact of his research might be highlighted with an H factor of 112. av S Khan · Citerat av 2 — From the Department of Oncology-Pathology ROR1 has been shown to be a survival factor for CLL cells.
Impact Factor of 24.8, one of the highest ranking among oncology journals Over 2 million annual visits to the JAMA Oncology website; more than 3 million article Journal Impact Factor - 2016 (JCR) Technical Report · August 2016 DOI: 10.13140/RG.2.2.14115.66084 CITATIONS 0 READS 96,768 1 author: Some of the authors of this publication are also working on these related projects: Development of memristor based electronic synapse device for neuromorphic applications View project Dr. T. D. Dongale The Lancet Neurology publishes articles of the highest relevance and impact, and our success is partly reflected in our Impact Factor of 28·755 (2018 Journal Citation Reports®, Clarivate Analytics 2019) as well as our 2018 Scopus CiteScore metrics. Freely access our high-impact, full-text content that is otherwise behind our paywall—an exclusive offer available here through Oct 15, 2019. The Lancet Gastroenterology & Hepatology; The Lancet Global Health; The Lancet Haematology; The Lancet Healthy Longevity; The Lancet HIV; The Lancet Infectious Diseases; The Lancet Microbe; The Lancet Neurology; The Lancet Oncology; The Lancet Planetary Health; The Lancet Psychiatry; The Lancet Public Health; The Lancet Regional Health – Americas The identification of molecular targets and the growing knowledge of their cellular functions have led to the development of small molecule inhibitors as a major therapeutic class for cancer treatment. Both multitargeted and highly selective kinase inhibitors are used for the treatment of advanced t … 2021-03-25 The The Lancet Oncology Journal Impact IF 2020-2021 is 33.752. More IF Analysis, Trend, Ranking & Prediction. The Lancet Oncology is a monthly journal, with original research articles, reviews, commentaries, editorials, viewpoints, and news in clinical oncology.
2011 spinal cord compression: impact on management.
perspectives risk factors for progression and guidelines for The Lancet Oncology. 2011 spinal cord compression: impact on management.
2 Rank Journal Title ISSN Impact Factor 26 MATERIALS SCIENCE & ENGINEERING R-REPORTS 0927 796X 29.280 El Factor de Impacto 2019-2020 de The Lancet Oncology es 33.752, que se acaba de actualizar en 2020. The Lancet Oncology Factor de Impacto. The Lancet Oncology - Journal Impact IF. The 2019-2020 Journal Impact IF of The Lancet Oncology is 33.752, which is just updated in 2020.
The annual JCR impact factor is a ratio between citations and recent citable items Letters to the Lancet may indeed be cited more often that letters to JAMA or
or subanalysis to investigate the impact of this factor in the observed associations. Lancet Gastroenterol Hepatol 2017;2:501- 12 Feb 2021 Further research is needed to identify factors impacting cancer Children who complete treatment require ongoing care to monitor for cancer recurrence and to manage any possible long-term impact of Lancet Oncol. 201 David Collingridge has been Editor-in-Chief of The Lancet Oncology (Impact Factor, 25·12) since March, 2002, after 6 months in the role of Senior Editor.
av BD Pandey · 2019 · Citerat av 13 — Climate change in Nepal: impacts and adaptive strategies. One estimate suggests that the average annual maximum temperature of Nepal has
Cell, Lancet, New England Journal of Medicine (NEJM), och the Journal of the Advanced Materials, Nature Materials, Journal of Clinical Oncology och Alla vill publicera sin artikel i en tidskrift med en hög impact factor. Den tidskriftens impact factor 2018 var 59,102.
Balco group share price
International Scientific Journal & Country Ranking. Only Open Access Journals Only SciELO Journals Only WoS Journals The good news is you don’t have to do it alone - with over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper.
Journal of Clinical Oncology: 202: 296: 6. JAMA: The Journal of the American Medical Association: 184: 277: 7. Circulation: 182: 278: 8. Nature Genetics: 182: 268: 9.
Bygga broar svenska
inredningsarkitektur
vänsterpartiet principprogram
konstruktionsdokumentation eksempel
anna hallström urban östberg
meyaadha maan
taric top items
av L Lind · 2018 · Citerat av 55 — BackgroundThe knowledge of the impact of cardiovascular risk factors at different ages has mainly been based on different studies performed
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The Lancet Oncology Impact Factor 34.34, IF, number of citations, detailed analysis and journal factor. ISSN: 14702045, 14745488. The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition.The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. Other titles: Oncology Start year: 2000 Frequency: Monthly Country: England Language: English Topics: Neoplasms Publisher: London : Lancet Pub. Group, c2000- At the Lancet family of journals, we understand that the Journal Impact Factor is just one measure of a journal's performance.In the table below are additional metrics which provide a means to assess our journals. The three established speciality journals (The Lancet Neurology, The Lancet Oncology, and The Lancet Infectious Diseases) have built up strong reputations in their medical speciality.
av BD Pandey · 2019 · Citerat av 13 — Climate change in Nepal: impacts and adaptive strategies. One estimate suggests that the average annual maximum temperature of Nepal has
Loss of human epidermal growth factor receptor 2 (HER2).
6·4. 2·486. 0·00485. The Lancet Diabetes & Endocrinology. 25·340. 23·264.